eBook: Multiplexing Phenotype and Function for More Biologically Relevant Insights
The drug development industry faces intense pressure to bring biologics and drugs to market more rapidly while mitigating the risk of late-stage failure.
To address these needs the industry requires highly advanced cell analysis platforms that have the ability to perform rapid, multiparametric analysis to get more relevant data upfront about the mechanism of action, and toxicity and thus compress discovery timelines.
This eBook reviews the technological advantages of an advanced flow cytometry platform that enables:
- Simultaneous analysis of cells and secreted proteins
- Miniaturized assays
- Faster time to actionable insights
